PSI’s Argentina Team Focuses on Driving Results for Sponsors in New Office 

PSI CRO, 17 December 2024 – PSI continues to grow its operational capabilities around the world with the PSI Argentina team’s move to a new office space in Buenos Aires. The team is transitioning from a traditional office setup to a dynamic coworking space at El Salvador 5218, Palermo, Buenos Aires City, Zip Code 1414 in the Palermo Soho neighborhood, a busy social and cultural hub. The move will allow for a smarter, more flexible work approach that helps the team better deliver on-time enrollment and meet key milestones.

PSI’s growth comes as Argentina continues to expand its clinical research presence, spurred on by a large patient population and the country’s regulatory authority, the National Administration of Drugs, Food and Medical Devices (ANMAT), known for its efficient approval timelines.* PSI has had a presence in Argentina since 2010, but the operations teams have doubled in size since 2017, with 64 operational staff currently in the area.

The space is located on the second floor of a modern business center. To guarantee secure confidentiality and data protection, PSI has exclusive and restricted access areas within the coworking facility, including private offices and dedicated meeting spaces.

“The team is excited to celebrate the new office, settling into the public coworking space, and secure offices that will help us ensure data security and privacy,” said Oscar Podesta, Head of Latin America, Country Management. “The new spaces are designed for both in-person and remote work, creating an environment where collaboration, creativity, and productivity come together to deliver on PSI’s promise of on-time enrollment.”

The announcement comes as part of PSI’s ongoing growth in Latin America, including a recent expansion to a new office in São Paulo, Brazil. To learn more about the new Argentina office or PSI’s full-service CRO capabilities, connect with us here.

About PSI: PSI CRO is a privately-owned, full-service clinical research organization (CRO) operating globally. PSI’s global reach supports clinical trials across multiple countries and continents and specializes in the planning and execution of global pivotal registration clinical trials. With an exceptionally high repeat and referral business rate combined with minimal staff turnover, PSI is committed to being the best CRO in the world as measured by its employees, customers, investigators, and vendors.

Global headquarters are located in Switzerland at 113a Baarerstrasse, Zug 6300. www.psi-cro.com

For Media Inquiries